O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

hypercalcemiaandhypocalemia-171210203910.pdf

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Próximos SlideShares
Hyper and hypocalcemia
Hyper and hypocalcemia
Carregando em…3
×

Confira estes a seguir

1 de 53 Anúncio

Mais Conteúdo rRelacionado

Semelhante a hypercalcemiaandhypocalemia-171210203910.pdf (20)

Mais recentes (20)

Anúncio

hypercalcemiaandhypocalemia-171210203910.pdf

  1. 1. HYPERCALCEMIA AND HYPOCALCEMIA Dr Govind Desai 1st Year Junior Resident Department of Pulmonary Medicine
  2. 2. TOPICS TO BE COVERED 1. ROLE OF CALCIUM 2.HOMEOSTASIS OF CALCIUM 3.HYPERCALCEMIA a)CAUSES b)CLINICAL FEATURES C)MANAGEMENT 4.HYPOCALCEMIA a)CAUSES b)CLINICAL FEATURES c)MANAGEMENT
  3. 3. Introduction Calcium is one of the most abundant mineral in the human body and it has many important biological Functions 1.2 kg to 1.4 kg of Ca is present normally in human Body 99% - in the skeleton Remaining amount -distributed in the ECF(0.25%) and other soft tissues(0.75%)
  4. 4. Distribution of calcium outside skeletal system In Blood , total Ca concentration is normally 8.5-10.5 mg/dl, of which approx 50% is ionized(normal value-4.8 mg/dl) Remainder is bound ionically to negatively charged proteins- Predominantly albumin and immunoglobulins or lossely complexed with PO4 , citrate ,SO4 and other anions
  5. 5. Protein binding of calcium Influenced by pH. Metabolic acidosis decrease protein binding increase ionized calcium. Metabolic alkalosis increase protein binding,decrease ionized calcium. *Fall in pH by o.1 increases ionized calcium by 0.1 mmol/L
  6. 6. As ionized form is the active form of calcium, serum calcium levels should be adjusted for abnormal serum albumin levels Corrected calcium For every 1-g/dL drop in serum albumin below 4 g/dL, measured serum calcium decreases by 0.8 mg/dL. Corrected calcium = Measured Ca + [0.8 x (4 - measured albumin)] (Calcium in mg/dl; albumin in g/dl)
  7. 7. FUNCTIONS of Calcium 1. Muscle contraction 2. Neuromuscular / nerve conduction 3. Intracellular signalling 4. Bone formation 5. Coagulation 6. Enzyme regulation 7. Maintainance of plasma membrane stability
  8. 8. HYPERCALCEMIA
  9. 9. Hypercalcemia is defined as total serum calcium > 10.2 mg/dl (>2.5 mmol/L ) or ionized serum calcium > 5.6 mg/dl ( >1.4 m mol/L ) Severe hypercalemia is defined as total serum calcium > 14 mg/dl (> 3.5 mmol/L) Hypercalcemic crisis is present when severe neurological symptoms or cardiac arrhythmias are present in a patient with a serum calcium > 14 mg/dl (> 3.5 mmol/L).
  10. 10. Hypercalcemia Causes I.Parathyroid-related -Primary hyperparathyroidism -Lithium therapy II. Malignancy-related -Solid tumor with metastases (breast) -Solid tumor with humoral mediation of hypercalcemia (lung, kidney) -Hematologic malignancies (multiple myeloma, lymphoma, leukemia) III. Vitamin D-related -Vitamin D intoxication - 1,25(OH)2D; sarcoidosis and other granulomatous diseases IV. Associated with high bone turnover -Hyperthyroidism -Immobilization -Thiazides V. Associated with renal failure -Severe secondary hyperparathyroidism -Aluminum intoxication -Milk-alkali syndrome
  11. 11. MECHANISM OF HYPERCALCEMIA IN LUNG CANCERS PRODUCTION OF HUMORAL FACTORS BY PRIMARY TUMOR,COLLECTIVELY KNOWN AS HUMORAL HYPERCALCEMIA OF MALIGNANCY(HHM) IN ALMOST 80 % OF CASES 1)TUMOR PRODUCED PARATHYROID HORMONE RELATED PROTEIN(PTHrp) 2)PRODUCTION OF 1,25 DIHYDROXYCALCITRIOL THE REST 20% ARE DUE TO METASTASIS TO THE BONE LEADING TO OSTEOLYSIS
  12. 12. NOTE Primary Hyperparathyroidism and Malignancies account for 90% of cases of hypercalcemia
  13. 13. Clinical Manifestations of Hypercalcemia Renal “stones” Nephrolithiasis Nephrogenic diabetes insipidus Dehydration Nephrocalcinosis
  14. 14. Skeleton “bones” Bone pain Arthritis Osteoporosis Osteitis fibrosa cystica in hyperparathyroidism (subperiosteal resorption, bone cysts)
  15. 15. Gastrointestinal “abdominal moans” Nausea, vomiting Anorexia, weight loss Constipation Abdominal pain Pancreatitis Peptic ulcer disease
  16. 16. Neuromuscular “psychic groans” Impaired concentration and memory Confusion, stupor, coma Lethargy and fatigue Muscle weakness Corneal calcification (band keratopathy)
  17. 17. Cardiovascular Hypertension Shortened QT interval on ECG Cardiac arrhythmias Vascular calcification
  18. 18. DIAGNOSTIC APPROACH HISTORY AND PHYSICAL EXAMINATION • NOTE:PATIENT WITH PRIMARY HYPERTHYROIDISM ARE USUALLY ASSYMTOMMATIC . • IF HYPERCALCEMIA IS PRESENT FOR MORE THAN 6 MONTHS PRIMARY HYPERTHYROIDISM IS MOST CERTAIN. • HYPERCALCEMIA WITH RENAL STONES FAVOURS LONG DURATION AND IS UNLIKELY DUE TO MALIGNANCY • USE OF VITAMIN D ,CALCIUM SUPPLEMENTATIONS AND LITHUIM SHOULD BE ASKED FOR IN HISTORY
  19. 19. INVESTIGATIONS 1. Serum Electrolytes 2. BUN,Creatinine 3. Serum Protein Electrophoresis 4. PTH levels 5. Chest Xray
  20. 20. NOTE • As a general rule, primary hyperparathyroidism is the etiology in opd patients who are assymptommatic with Sr Ca Concentrations of <11.0 mg/dl • On the other hand malignancy is often the cause in symptommatic patients with abrupt onset and serum calcium levels higher than 14 mg/dl
  21. 21. TREATMENT • MEASURES TO INCREASE URINARY EXCRETION • MEASURE TO INHIBIT BONE RESORPTION • MEASURE TO DECREASE INTESTINAL ABSORPTION • SPECIFIC TREATMENT
  22. 22. MEASURES TO INCREASE URINARY EXCRETION 1) Volume Restoration expansion and saline diuresis are most useful and effective measures to correct hypercalcemia 0.9 % NaCl is infused to correct dehydration for volume expansion and diuresis.(almost 4-6 litres is required to cause flushing of calcium)hence always use cautiously in HEART FAILURE AND ELDERLY patients to avoid pulmonary oedema 2)FURUSEMIDE – Additive effect with 0.9 NS as it leads to forced Diuresis. 3)HAEMODIALYSIS- Reserved for treatment of patients with severe hypercalcemia and in CRF
  23. 23. MEASURE TO INHIBIT BONE RESORPTION 1)BISPHOSPHONATES- PAMIDRONATE is the most potent and most widely used bisphosphonate DOSAGE-60-90 mg IV over 4 hours 2)PLICAMYCIN-Rarely used owing to high toxicity 3)CALCITONIN MOA-Inhibits bone resorption and increases urinary excretion useful in acute crisis DOSAGE-4IU/KG s.c 12hourly
  24. 24. MEASURE TO DECREASE INTESTINAL ABSORPTION GLUCOCORTICOIDS CAUSES DECREASED ABSORPTION AND INCREASES URINARY EXCRETION ARE EFFECTIVE IN SARCOIDOSIS,MALIGNANCY,VIT D TOXICITY BUT NOT IN PRIMARY HYPERPARATHYROIDISM ORAL PHOSPHATES
  25. 25. SPECIFIC TREATMENT 1. Discontinue drugs responsible 2. Surgical treatment in primary hyperparathyroidism 3. Specific treatment in cases of malignancy and granulomatous conditions
  26. 26. HYPOCALCEMIA
  27. 27. HYPOCALCEMIA A decrease in the SERUM CALCIUM <8.5mg/dl or IONIZED CALCIUM <3-4.4mg/dL is termed as hypocalcemia
  28. 28. CAUSES OF HYPOCALCEMIA 1)HYPOALBUMINEMIA 2)HYPOPARATHYROIDISM a)Post Surgical b)Idiopathic 3)DEFECT IN VITAMIN D METABOLISM a)Nutritional b)Malabsorption and Drugs(anticonvulsants) c)Liver and Renal diseases 4)MISCELLANEOUS a)Metabolic or Respiratory Alkalosis b)Sepsis c)Massive Blood transfusion d)Tumour lysis e)Rhabdomyolysis
  29. 29. NOTE In Hypoalbuminemia the Total calcium levels are reduced but ionized calcium is normal
  30. 30. HISTORY 1. REDUCED FOOD/NUTRITIONAL INTAKE 2. H/O SURGERY OF PARATHYROID 3. H/O RADIATION 4. H/O BLOOD TRANSFUSION
  31. 31. CLINICAL FEATURES 1. WEAKNESS 2. CIRCUMORAL PARAESTHESIA 3. DISTAL EXTREMITY PARAESTHESIA 4. MUSCLE SPASM 5. CARPOPEDAL SPASM 6. TETANY 7. IRRITABILITY/DEPRESSION/PSYCOSIS
  32. 32. PHYSICAL EXAMINATION 1)CHVOSTEK’S SIGN 2)TROSSEAU’S SIGN
  33. 33. INVESTIGATIONS • Serum Calcium (Total and Ionic calcium) • Serum Albumin (3.5-5.3g/dL) • Serum Phosphorus (2.7-4.5mg/dL) • Serum Magnesium (0.7-1.0mmol/L) • Urinary calcium excretion (100-250mg/24h) • RFT • 25-hydroxyvitamin D levels (>20ng/ml) • Serum PTH (10-65pg/ml) *ECG-PROLONGED QT INTERVAL
  34. 34. TREATMENT • ACUTE MANAGEMENT • LONG TERM MANAGEMENT • VITAMIN D SUPPLEMENTATION
  35. 35. ACUTE MANAGEMENT • Goals of Therapy • Total Serum Ca 8.6-10.2 mg/dl (2.15-2.55 mmol/L) or • Ionized serum Ca > 4.5 mg/dl or > 1.12 mmol/L • Manage underlying illness
  36. 36. Management Mild to moderate : Oral supplementation IV Calcium Intermittent iv boluses for severe symptomatic (total serum ca < 7.5 mg/dl or < 1.9 mmol/L) or ionzied Ca < 4 mg/dl or < 1 mmol/L Symptomatic hypocalcemia is an emergency Administer 1 g Calcium chloride or Ca Gluconate(1000 mg of elemental calcium/10ml) iv over 10 minutes Refractory hypocalcemia: Continuous infusion of elemental calcium
  37. 37. NOTE: AVOID RINGER LACTATE WHEN INFUSING CALCIUM PREPARATIONS
  38. 38. Mx OF SEVERE SYMPTOMMATIC HYPOCALCEMIA
  39. 39. LONG TERM MANAGEMENT TREATMENT OF UNDERLYING CAUSE ORAL ELEMENTAL CALCIUM 1-3gm /DAYGIVEN BETWEEN MEALS VITAMIN D SUPPLEMENTATION
  40. 40. TAKE HOME MESSAGE 1)Metabolic acidosis decrease protein binding increase ionized calcium. Metabolic alkalosis increase protein binding,decrease ionized calcium. 2)Corrected calcium For every 1-g/dL drop in serum albumin below 4 g/d L, measured serum calcium decreases by 0.8mg/dL. 3) ALWAYS RULE OUT MALIGNANCY WHEN PATIENT PRESENTS WITH ACUTE HYPERCALCEMIA 4)GLUCOCORTICOIDS ARE USEFUL IN Mx OF HYPERCALCEMIA
  41. 41. TAKE HOME MESSAGE 5) 6)CHVOSTEK’S SIGN &TROSSEAU’S SIGN are specific physical signs of hypocalcemia 7) AVOID RINGER LACTATE WHEN INFUSING CALCIUM PREPARATIONS In Hypoalbuminemia the Total calcium levels are reduced but ionized calcium is normal
  42. 42. REFERENCES 1. Practical Guidelines on fluid therapy-Dr Sanjay pandya 2. Harrisons textbook of internal medicine 3. NCBI/PUBMED 4. https://en.ecgpedia.org/wiki/Electrolyte_Dis orders 5. emedicine.medscape.com/article/766373- workup
  43. 43. THANK YOU

×